Wurster, Claudia D.
Winter, Benedikt
Wollinsky, Kurt
Ludolph, Albert C.
Uzelac, Zeljko
Witzel, Simon
Schocke, Michael
Schneider, Ralf
Kocak, Tugrul
Article History
Received: 6 August 2018
Revised: 10 November 2018
Accepted: 13 November 2018
First Online: 20 November 2018
Compliance with ethical standards
:
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. CDW has received honoraria from Biogen as an advisory board member and for lectures and as a consultant from Hoffmann-La Roche. ACL has received financial research support from AB Science, Biogen Idec, Cytokinetics, GSK, Orion Pharam, Novartis, TauRx Therapeutics Ltd., and TEVA Pharmaceuticals, and has received honoraria as a consultant from Mitsubishi, Orion Pharma, Novartis, Teva and as an advisory board member from Biogen, Treeway, and Hoffmann-La Roche. ZU has received honoraria from Biogen as a consultant. BW has received honoraria from Biogen for a lecture. SW, KW, MS, RS, and TK report no disclosures relevant to the manuscript.
: The study was approved by the local ethics committee and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Patients or their relatives gave informed consent to participate in the study.
: Demographic and clinical data on motor functions of the investigated patients are provided to the German Network for Motor Neuron Diseases (MND-NET).